Rodrigo DeAntonio

Efficacy and safety of the CVnCoV SARS-CoV-2 mRNA vaccine candidate in ten countries in Europe and Latin America (HERALD): a randomised, observer-blinded, placebo-controlled, phase 2b/3 trial

Peter G. Kremsner, Rodolfo Andrés Ahuad Guerrero, Eunate Arana‐Arri et al. · The Lancet Infectious Diseases · 2021 · 170 citations · Full text

Postmarketing Surveillance of Intussusception Following Mass Introduction of the Attenuated Human Rotavirus Vaccine in Mexico

F. Raúl Velázquez, Rómulo E. Colindres, Concepción Grajales-Muñíz et al. · The Pediatric Infectious Disease Journal · 2012 · 115 citations

Safety and immunogenicity of a tetravalent dengue vaccine in children aged 2–17 years: a randomised, placebo-controlled, phase 2 trial

Vianney Tricou, Xavier Sáez‐Llorens, Delia Yu et al. · The Lancet · 2020 · 103 citations

Vaccination, Vaccine Safety, Vaccinology +6

Safety and immunogenicity of two novel type 2 oral poliovirus vaccine candidates compared with a monovalent type 2 oral poliovirus vaccine in children and infants: two clinical trials

Xavier Sáez‐Llorens, Ananda S Bandyopadhyay, Christopher Gast et al. · The Lancet · 2020 · 77 citations · Full text

Impact of rotavirus vaccination on childhood gastroenteritis-related mortality and hospital discharges in Panama

Vicente Bayard, Rodrigo DeAntonio, Rodolfo Contreras et al. · International Journal of Infectious Diseases · 2011 · 62 citations · Full text